Skip to main content

Here's how one drug can be responsible for 50% of the hike in Medicare's Part B premiums

About half of the jump in Part B premiums next year is due to the potential cost of covering Aduhelm, a drug targeting Alzheimer's disease. Here's why.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.